NYSE - Delayed Quote USD

Concentra Group Holdings Parent, Inc. (CON)

Compare
23.07 +0.22 (+0.96%)
At close: September 11 at 4:00 PM EDT
Loading Chart for CON
DELL
  • Previous Close 22.85
  • Open 22.62
  • Bid 21.30 x 800
  • Ask --
  • Day's Range 22.29 - 23.28
  • 52 Week Range 21.37 - 24.81
  • Volume 122,978
  • Avg. Volume 681,894
  • Market Cap (intraday) 2.921B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 22.62
  • EPS (TTM) 1.02
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 29.79

Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational and consumer health services, including workers' compensation injury care, urgent care, clinical testing, preventative care, and employer services, as well as wellness programs through occupational health centers and onsite clinics. It also provides Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.

www.concentra.com

11,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CON

View More

Performance Overview: CON

Trailing total returns as of 9/11/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CON
4.86%
S&P 500
2.87%

1-Year Return

CON
4.86%
S&P 500
2.87%

3-Year Return

CON
4.86%
S&P 500
2.87%

5-Year Return

CON
4.86%
S&P 500
2.87%

Compare To: CON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CON

View More

Valuation Measures

Annual
As of 9/11/2024
  • Market Cap

    2.92B

  • Enterprise Value

    3.73B

  • Trailing P/E

    22.58

  • Forward P/E

    18.02

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.57

  • Price/Book (mrq)

    2.34

  • Enterprise Value/Revenue

    2.01

  • Enterprise Value/EBITDA

    10.40

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.76%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.86B

  • Net Income Avi to Common (ttm)

    181.6M

  • Diluted EPS (ttm)

    1.02

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    50.67M

  • Total Debt/Equity (mrq)

    67.77%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: CON

View More

Company Insights: CON

Research Reports: CON

View More

People Also Watch